ISTH 2021 Congress Archives - Page 91 of 91

Abstract Number: PB0546

Ultrasound Assessment of the Joint Status in Hemophilia Patients under Prophylaxis Using the Hemophilia Early Arthropathy Detection with Ultrasound (HEAD-US) Score

I. Ricca¹, B. Pollio¹, R. Albiani¹, C. Martinoli²
Abstract Number: PO110

Ultrasound-guided Balloon Angioplasty of Occluded Artery Accompanied by Combined Electrohydraulic Low Level Shock Wave Therapy and 125I- Mediated Gamma-intravascular Brachytherapy

H. Mehrad^1,2, H. Ahmadi Noubari^3,2
Abstract Number: PO102

Ultrasound-guided Catheter-based ¹⁹²Ir -mediated β^–brachytherapy of Neointimal Hyperplasia Accompanied by Protoporphyrin IX–loaded Microbubbles-mediated Pulsed Low Level Focused Ultrasound Sonodynamic Therapy

H. Mehrad^1,2, H. Ahmadi Noubari^3,2
Abstract Number: PO107

Ultrasound-guided Laser-mediated Thermal Angioplasty of Occluded Artery Accompanied by Combined 5-Aminolevulinic Acid-loaded Microbubbles-mediated Photodynamic Therapy and Catheter-based ¹⁹²Ir-mediated β^–brachytherapy

H. Mehrad^1,2, H. Ahmadi Noubari^3,2
Abstract Number: PB0691

Unclassified Bleeding Disorders and Inherited Platelet Function Disorders: Response to Desmopressin Challenge

M. Desborough¹, J. Alamelu², S. Austin¹, G. Ling¹, E. Foxton³, A. McCormick³, G. Dolan¹, B. Madan¹
Abstract Number: PB0499

Understanding the burden of Care for Haemophilia in the UK: Direct Medical Costs and Associated Predictors from the CHESS I and II Studies

I. Woollacott¹, A. Chhabra¹, J. Brownrigg¹, T. Burke², A. Shaikh², J. O'Hara², J. Godfrey³, M. Laffan⁴
Abstract Number: OC 61.4

Understanding the Role of Mitochondria in Platelet Function

K.S. Prakhya¹, Y. Luo², H. Vekaria¹, J. Adkins¹, X. Hu², P. Sullivan¹, Q. Wang¹, S. Whiteheart¹
Abstract Number: OC 04.3

Unraveling Mild Antithrombin Deficiency with Mass Spectrometry in a Patient Presenting with Recurrent Pregnancy Loss

M. Kruijt¹, L.M. van der Pol², J. Eikenboom², H.J. Verburg³, C.M. Cobbaert¹, L.R. Ruhaak¹
Abstract Number: PO168

Unusual Laboratory Presentation of Lupus Anticoagulant: Prolonged Prothrombin Time (PT) and Activated Partial Thromboplastin Time (APTT) without Severe Factor Deficiency

C. Guedes¹, L. Barbosa², D. Marques¹, J. Silva¹, T. Luís¹, R. Salvado¹, J. Tomaz¹
Abstract Number: PB0603

Update on Real Life Use of Emicizumsb in Pediatric Patients without Inhibitors

S. Heine¹, N. Graf¹
Abstract Number: PB0510

Updates on the Atlanta Protocol Cohort: Two-year Institutional Outcomes on Immune Tolerance Induction in Children with Hemophilia A and Inhibitors on Emicizumab

G. Batsuli¹, K. Zimowski¹, K. Tickle², S.L. Meeks¹, R.F. Sidonio¹
Abstract Number: PB0862

Urgent Cardiac Surgery in a Patient with Heparin Induced Thrombocytopenia

M. Romić¹, D. Mišura¹, G. Tomac², M. Čikeš^1,3, H. Gašparović^1,4, A. Boban^1,5
Abstract Number: PB0643

Urosurgical Management in Mild Hemophilia with Inhibitor: A Case Report

L. Phillips¹, M. Movassaghi², C.P. Carpenter², D. Kaur¹
Abstract Number: PB0322

Use of Blood Products and Hemostatic Agents during Massive Transfusions: Review of our Practice

G.S. Ene¹, L. Edo Caballero², N. Tamayo Ubeda², A. Carpi Medina², N. Palo Mauriz², A. Villauvi Serra², A. Bolivar Lopez¹, P. Sanchez Coronado¹, I. Sanchez Ron², C. Raya Hinojosa², J.C. Alvarez Garcia²
Abstract Number: PB0223

Use of D-Dimer as a Predictor of Venous Thromboembolism Events (VTE) in Covid-19 Patients

M.C. Chindamo^1,2, M.B. Manhães¹, L.D. Carvalho¹, G.G. Sardinha¹, A.M. Marques¹, H.C. Goudar¹, A.B. Nunes¹, P.R. Carmo Jr^1,2, D.R. Salgado^1,2
Abstract Number: PB1080

Use of Dabigatran Assessed By Thrombin Generation Assay (TGA): Paradoxical Results

R. Duarte¹, C. Ferreira², E. Figueiredo³, G. Lopes⁴, L. Paes⁵, D. Rios⁶, M. Carvalho¹
Abstract Number: PB0531

Use of Desmopressin in the Treatment of Bleeding in Non-severe Hemophilia A

A. Zwagemaker¹, F.R. Kloosterman¹, S.C. Gouw^1,2, E.A.M. Beckers³, S. Boyce⁴, P. Collins⁵, J. Eikenboom⁶, S. Shapiro⁷, S. Jackson⁸, M.J.H.A. Kruip⁹, B. Laros-Van Gorkom¹⁰, L. Nieuwenhuizen¹¹, I. Pabinger¹², M. Coppens¹³, J.G. Van der Bom^2,14, G. Castaman¹⁵, K. Fijnvandraat^1,16, DYNAMO Study Group
Abstract Number: PB0310

Use of MRX PT DOAC in a Routine Laboratory Setting for Detection of Interfering DOACs in Thrombophilia Investigation

T. Lindahl¹, M. Lund¹, K. Arbring², L. Onelöv³
Abstract Number: PB0334

Use of Rotational Thromboelastometry (ROTEM) to Monitor Patients with Severe Haemophilia A on Emicizumab

A. Riddell¹, P. Lane¹, J. Kemp¹, T. Gandhi¹, P. Chowdary¹
Abstract Number: PB0783

Use of Single Photon Emission Computed Tomography and Arthrocentesis in the Management of Hip Hemarthrosis in Hemophilia A

J. Mooney¹, P. Moorehead¹, H. Martin¹, A. Pickles¹.
Abstract Number: OC 73.4

Use of the National Early Warning Score for Predicting Deterioration of Patients with Acute Pulmonary Embolism

R. Bavalia¹, M.A.M. Stals², FI Mulder¹, IM Bistervels^1,3, M Coppens¹, LM Faber⁴, SV Hendriks^2,5, HMA Hofstee⁶, MV Huisman², T van der Hulle², ATA Mairuhu⁵, MJHA Kruip⁷, S Middeldorp^1,8, FA Klok², BA Hutten⁹, F Holleman¹⁰
Abstract Number: LPB0108

Usefulness of an Academic High-throughput Sequencing Panel to Detect Copy Number Variations in Patients with Syndromic Thrombocytopenia

S. Santos-Mínguez¹, C. Miguel-García¹, V. Ramírez-Maldonado¹, I. Serramito-Gómez¹, A. Marín-Quilez¹, J. Matías-Martín¹, J.R. González-Porras^1,2, H. González-García³, J. Huerta-Aragonés⁴, C. Blázquez-Goñi⁵, A. Rodríguez-Alén⁶, C. García-Diaz⁷, E. Urbaneja-Rodríguez³, A. Hortal Benito-Sendín⁸, N. Revilla⁹, V. Palma-Barqueros⁹, J. Rivera⁹, J.M. Hernández-Rivas^1,2, J.M. Bastida^1,2, R. Benito¹
Abstract Number: PB0596

Usefulness of Clot Waveform Analysis as a Perioperative Monitoring in Arthroscopic Synovectomy to a Pediatric Patient with Hemophilia A and Inhibitor Receiving Emicizumab

K. Mizumachi¹, Y. Tsumura², Y. Nakajima¹, K. Ko², K. Nogami¹
Abstract Number: PB0480

Usefulness of Global Coagulation Assays to Monitor Emicizumab Therapy

D. Bertaggia Calderara¹, M.G Zermatten¹, A. Aliotta¹, A.P Batista Mesquita Sauvage¹, L. Alberio¹
Abstract Number: PB1248

Usefulness of Measuring Anti–Factor Xa Activity to Guide the Treatment with Low-molecular-weight Heparins in Patients with Acute Pulmonary Embolism

J. Bonorino¹, J. Bilbao¹, H. Fernandez¹, N. Torres¹, M. Iwanowski¹, P. Alarcon¹, R. Melchiori¹, J. Santucci¹, M.E. Aris Cancela¹, P. Colimodio¹, C. Rosa¹, M.C. Ferrario¹, P. Rubio¹, S. Marquez¹, G. Garcia¹, M. Bivort¹, A. Sanchez¹, N. Perez Caceres¹, S. Baratta¹, A. Hita¹
Abstract Number: PB0562

User Evaluation of a Home-treatment Recording Smartphone App

M. O'Donovan^1,2, N. Larkin¹, E. Singleton¹, J. Benson¹, F. McGroarty¹, J. Farrelly³, C. Bergin¹, R. Bird¹, C. Buckley¹, J.S. O'Donnell¹, K. Ryan¹, N.M. O'Connell^1,2
Abstract Number: PB1251

Using an App to Educate Patients on the Pros and Cons of Extended Anticoagulation after Venous Thromboembolism: A Randomized Controlled Trial

M.A. de Winter¹, T. Timmers^2,3, M.M.C. Hovens⁴, A. Iglesias del Sol⁵, A.T.A. Mairuhu⁶, H.A.H. Kaasjager¹, M. Nijkeuter¹
Abstract Number: PB1226

Using the Caprini Risk Score to Increase VTE Awareness in the Community. The Know Your Score Project

P. Shetye¹, S. Gavankar¹, H. Saadaldin^2,3, A. Tafur^4,5, J. Caprini^4,5
Abstract Number: PB1266

Using the Functional Resonance Analysis Method to Explore how Elastic Compression Therapy Is Organized and Could Be Improved

R.H. Schreurs^1,2,3, M.A. Joore⁴, H. Ten Cate^1,2,3, A.J. Ten Cate-Hoek^1,2
Abstract Number: PB0034

USP Potency Adjusted Bovine Mucosal Heparins Are Comparable to Porcine Mucosal Heparin and may be interchangeable for anticoagulation

A. Kouta¹, N. Baig¹, W. Jeske¹, D. Hoppensteadt¹, M. Iacobelli¹, O. Iqbal¹, M. Bakhos¹, J. Fareed¹
Abstract Number: PB0922

Utility of a New, Rapid Automated von Willebrand Factor (VWF) Multimer Assay for the Diagnosis of von Willebrand Disease

J. Brodard¹, R. Rubin², D. Baumgarnter², M. Reusser², J.A Kremer, Hovinga²
Abstract Number: PB0785

Utility of Antithrombotic Therapy in Pediatric Portal Vein Thrombosis after Endovascular Procedure

K. Na¹, R. Diaz¹, J. Hernandez¹, H. Justino¹, C. Cohen¹, S. Sartain¹, Y. Lee-Kim¹
Abstract Number: PB0411

Utility of Lysis Time (Global Fibrinolytic Capacity) Assay for Detection of Hyperfibrinolysis in Trauma

A. Rossetto^1,2, T. Torres², S. Platton², P. Vulliamy^1,2, R. Davenport^1,2
Abstract Number: PB0897

Utility of Modified Ivy’s Bleeding Time and Closure Time on Platelet Function Analyzer-200 as a Screening Tool to Identify Platelet Function Disorders

R. Dave¹, T. Geevar¹, J. Mammen¹, G. Chellaiya¹, A. Samuel¹, R. Vijayan¹, S. Singh¹, S. Nair¹
Abstract Number: PB0389

Utility of Platelet Parameters in Pediatric Outpatient Setting: Experience from a Single Institution

R. Natesirinilkul¹, S. Manowong¹, P. Saihikam¹
Abstract Number: PB1296

Utility of Royal College of Obstetricians and Gynaecologists (RCOG) Guidelines in Preventing Pregnancy Related Venous Thrombo-embolism (PA-VTE)

E. Jackson¹, E. Treharne¹, A. Alexander¹, B. Myers²
Abstract Number: PB0355

Utility of the STG-Bleedscreen Assay in Clinical Routine

T. Siegemund¹, A. Siegemund¹, H. Bönigk¹
Abstract Number: PB0973

Utilizing CRISPR-CAS9 Gene Editing Technology in Human Pluripotent Stem Cells to Study Platelet Integrin αIIbβ3 Function

K.P.Y. Fong¹, C. Jobaliya², J.A. Maguire², M. Poncz², D.L. French², J.S. Bennett¹